Products & Services · Year Nine

Multi-line and other specialty — Year Nine

Arch Capital Group Multi-line and other specialty — Year Nine increased by 37.5% to 1.1% in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 37.5%, from 0.8% to 1.1%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

Stable or increasing results indicate a robust specialty insurance franchise capable of navigating long-term market shifts.

Detailed definition

This metric captures the financial performance of the multi-line and specialty insurance segment in the ninth year of th...

Peer comparison

Similar to long-term segment performance tracking used by global insurance conglomerates.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_nine

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value0.8%0.4%0.4%0.8%1.1%
QoQ Change-50.0%+0.0%+100.0%+37.5%
YoY Change-50.0%+0.0%+100.0%+37.5%
Range0.4%1.1%
CAGR+37.5%
Avg YoY Growth+21.9%
Median YoY Growth+18.7%
Current Streak3 quarters growth

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year nine?
Arch Capital Group (ACGL) reported multi-line and other specialty — year nine of 1.1% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year nine changed year-over-year?
Arch Capital Group's multi-line and other specialty — year nine increased by 37.5% year-over-year, from 0.8% to 1.1%.
What does multi-line and other specialty — year nine mean?
The financial performance of the multi-line and specialty insurance segment in the ninth year of the reporting period.